Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 24029745.
- Also identified by DOI 10.1136/thoraxjnl-2013-203988.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In sarcoidosis, chronic pulmonary aspergillosis (CPA) may be associated with significant morbidity, and treatment failure rates are often high, even with newer triazole antifungal agents. We report a treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles.
Medical subject headings
- Antifungal Agents
- Echinocandins
- Pulmonary Aspergillosis
- Sarcoidosis